关于胰腺癌发病,进展和治疗耐药性的血统可塑性的新兴见解
Xintong Zhang1, Yaru Du1, Axel Behrens2
1Research Centre, Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China; Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
Developmental cell
|September 23, 2025
概括
血统可塑性使细胞身份变化成为可能,这在发育和癌症中至关重要. 在胰腺癌中,它驱动瘤的进展,异质性和治疗耐药性,提供治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 发展生物学 发展生物学
背景情况:
- 血统可塑性允许细胞改变身份,这对发育和再生至关重要.
- 瘤细胞利用血统可塑性进行癌症发病,进展,转移和治疗抵抗.
- 瘤内异质性 (ITH) 受到血统可塑性的显著影响.
研究的目的:
- 审查血统可塑性在胰腺管道腺癌 (PDAC) 中的作用.
- 讨论胰腺中的正常和瘤细胞如何获得血统可塑性.
- 探索血统可塑性对PDAC病变发生,ITH,转移和治疗耐药性的影响.
主要方法:
- 对PDAC中血统可塑性研究的文献综述.
- 分析诸如膜-导管形转化 (ADM),膜-导管形重编程 (ADR) 和上皮-介质细胞过渡 (EMT) 等机制.
- 在PDAC中检查癌症干细胞 (CSC) 再生和分子亚型重新连接.
主要成果:
- 血统可塑性是PDAC发展的核心,驱动ADM,ADR,EMT和CSC再生.
- 由可塑性塑造的多种血统轨迹有助于PDAC的进展和治疗结果.
- 血统可塑性机制在PDAC中产生了显著的内异质性.
结论:
- 了解PDAC的谱系可塑性对于破译其病原和异质性至关重要.
- 针对血统可塑性的关键调节者,为PDAC提供了一个有前途的治疗策略.
- 血统可塑性显著影响PDAC转移和对治疗的抗性.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


